Momenta Pharmaceuticals Inc

More

• RESEARCH ALERT-Momenta Pharmaceuticals: Canaccord Genuity raises target price Wednesday, 1 May 2013 | 5:59 AM ET

  May 1- Momenta Pharmaceuticals Inc:. *Canaccord Genuity raises target price to $13 from $12; rating hold. Reuters Station users, click. 1568.

• Biotech's a Buy, but Hold Off on HMOs: Fund Manager Wednesday, 9 Jan 2013 | 2:02 PM ET

  

  Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.

• 13 Biotech Stock Predictions for 2013 Wednesday, 2 Jan 2013 | 7:55 AM ET

  

  TheStreet.com offers up 13 biotech predictions for 2013.